Current Appointments & Affiliations
Biostatistician, Principal
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials.
Journal Article Circulation · March 30, 2026 BACKGROUND: Clinical endpoint classification (CEC) is the gold standard for cardiovascular endpoint measurement in clinical trials, but adds time and cost. We developed and validated an artificial intelligence (AI) algorithm (ADAPT-CEC) that adjudicates mu ... Full text Link to item CiteContemporary Trends, Characteristics, and Outcomes of Patients Undergoing Percutaneous Coronary Intervention for Stent Thrombosis.
Journal Article JACC Cardiovasc Interv · March 9, 2026 BACKGROUND: There are limited data regarding the temporal trends and outcomes of stent thrombosis (ST) in the contemporary era of potent P2Y12 inhibitors, newer generation drug-eluting stents, and intracoronary imaging. OBJECTIVES: The aim of this study wa ... Full text Link to item CiteRadial vs femoral access for percutaneous coronary intervention: temporal trends and outcomes in the USA.
Journal Article Eur Heart J · February 9, 2026 BACKGROUND AND AIMS: Radial access site for percutaneous coronary intervention (PCI) is recommended by clinical practice guidelines because of superior outcomes compared with femoral access site. Historically, the adoption of radial access site in the USA ... Full text Link to item CiteRecent Grants
Improving Quality of Life in SLE by Stratified Personalized Health Planning
ResearchBiostatistician · Awarded by Department of Defense · 2022 - 2026Secondary Analyses to Support the Rational Design of Clinical Trials in Chronic Lung Allograft Dysfunction
ResearchBiostatistician · Awarded by National Institutes of Health · 2023 - 2025Debiasing Clinical Care Algorithms
ResearchStatistical Programmer · Awarded by American Heart Association · 2024 - 2025View All Grants